EVIDENCE. COMPARISONS. CLEAR NEXT STEPS.FOR US CLINIC TEAMS PROCUREMENT RESEARCH
Direct questions

23. What DSCSA checks apply to GLP-1 procurement?

Dose Diligence research deskSection 01 · Page 23 of 34Last updated 17 Nov 2026

Determine applicability by product and trading-partner role; do not assume every clinic has identical obligations. For applicable transactions, verify authorized trading partners, required tracing records and suspect-product procedures. FDA’s pharmacy guidance describes these responsibilities. (fda.gov)

There is an important current-date distinction: FDA has published an additional small-business-dispenser exemption period extending certain requirements from November 27, 2026 through November 27, 2027. It does not exempt all parties or eliminate every verification requirement. (fda.gov)

Ask counsel and supply-chain leadership to document:

  1. The entity’s role in each transaction.
  2. Whether the product and transaction fall within scope.
  3. Which requirements apply now.
  4. Any exemption relied upon and evidence of eligibility.
  5. Which obligations remain despite that exemption.
  6. Where records reside and who can retrieve them during a recall.

Do not use a network’s prescriber count as a proxy for eligibility under a dispenser-specific exemption.

Sources cited on this page

  1. fda.gov · Source 1 ↗https://www.fda.gov/drugs/drug-supply-chain-security-act-dscsa/pharmacists-utilize-dscsa-requirements-protect-your-patients?utm_source=openai
  2. fda.gov · Source 2 ↗https://www.fda.gov/media/194424/download?trk=public_post_comment-text
Section sources →